Picture of Biosenic SA logo

BIOS Biosenic SA Cashflow Statement

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Biosenic SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11.5-9.58-17.4-12-2.32
Depreciation
Non-Cash Items-3.31-4.64-2.18-1.42-0.001
Other Non-Cash Items
Changes in Working Capital1.33.062.940.4730.349
Change in Accounts Receivable
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-12.9-10.4-16.1-12.8-1.91
Capital Expenditures-0.296-0.31-0.093-0.207-0.005
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0010.008120.0031.96
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities-0.295-0.30211.9-0.2041.95
Financing Cash Flow Items-0.805-0.86-3.83-1-0.203
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1311.210.27.851.04
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.2370.4596.01-5.141.09
0